Immune Profiling Platform HealthTell’s immune profiling platform enables deep biomarker discovery and therapeutic monitoring, ideal for pharma programs in autoimmune, cancer, CNS, and infectious diseases seeking target discovery and patient stratification pilots.

Central Lab Advantage Leverage HealthTell’s high-throughput centralized lab in San Ramon and its ISO-based quality framework to offer scalable, regulated immune profiling services, including assay development and monitoring panels for clinical development programs.

Regulatory Edge With prior leadership in Regulatory and Quality, there is a ready pathway to provide regulatory strategy and quality assurance support as an add-on to profiling services, helping clients advance diagnostics and biomarker claims more efficiently.

Strategic Partnerships As a small team, HealthTell can accelerate growth through partnerships with CROs and biopharma firms—offering preferred access to its platform via joint development agreements, white-labeled services, or revenue-sharing models to scale adoption.

Market Focus Target growth within autoimmune, cancer, CNS, and infectious disease pipelines, with Bay Area and West Coast biotech access to accelerate early collaborations, pilot programs, and co-development opportunities.